| Financial Year |
March 31 2023 |
| Monetary Funds |
187,470,860.13 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,082,478.30 |
| Accounts Receivable |
425,957,559.70 |
| Advances to Suppliers |
34,131,105.29 |
| Other Receivables |
28,966,917.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
271,713,660.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
5,983,050.11 |
| Other Current Assets |
22,377,291.71 |
| Total Current Assets |
991,753,787.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
7,271,399.47 |
| Long-term Equity Investment |
1,206,970.07 |
| Investment Properties |
5,753,169.36 |
| Fixed Assetes |
107,177,158.05 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
48,380,095.56 |
| R&D expenses |
28,599,599.10 |
| Goodwill |
190,909,001.78 |
| Long-Term Deferred and Prepaid Expenses |
4,926,631.52 |
| Deferred Income Tax Assets |
14,949,412.85 |
| Other Non-Current Assets |
10,449,757.16 |
| Sub-Total of Non-Current Assets |
469,913,423.01 |
| Total Assets |
1,461,667,210.86 |
| Short-Term Loans |
40,178,654.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,571,492.10 |
| Accounts Payable |
225,866,470.25 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,471,986.25 |
| Taxes Payable |
4,991,006.89 |
| Interest Payable |
-- |
| Dividend Payable |
6,000,000.00 |
| Other payables |
20,486,701.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,663,849.60 |
| Other Current Liabilities |
7,381,622.97 |
| Sub-Total of Current Liabilities |
556,151,442.63 |
| Long-term Loans |
1,080,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,659,917.78 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,639,653.68 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
46,657,112.42 |
| Total Liabilities |
602,808,555.05 |
| Paid-In Capital(Or Share Stock) |
640,557,569.00 |
| Capital Surplus |
534,068,728.52 |
| Surplus Reserve |
24,173,679.66 |
| LESS:Treasury Stock |
1,614,525.00 |
| Undistributed Profits |
-379,682,465.69 |
| Minority Stockholder's Interest |
53,142,790.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
805,715,865.36 |
| Owner's Equity（Stockholder's Equity） |
858,858,655.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,461,667,210.86 |
